Isotonix®菠蘿酵素沖飲

哪些人應食用Isotonix菠蘿酵素沖飲？

Isotonix菠蘿酵素沖飲適合任何人士每天飲用。它集合多項優點，同時支援人體自我修復的正常能力及身體的正常癒合過程，亦可支援細胞健康等。Isotonix菠蘿酵素沖飲適合想擁有健康身體、支撐身體日常機能的成人食用，以應付每天生活上帶來的侵害。

如何食用Isotonix菠蘿酵素沖飲？

將三小瓶蓋（白色螺旋蓋）的粉末倒入杯中，加入180毫升的水（瓶杯線為60毫升），攪拌後飲用。本產品為健康食品，每天飲用一次或按醫護人員指示飲用。空肚飲用效果最佳。使用規定量的粉劑與水混合才會使本產品達到等滲狀態。

菠蘿酵素從何而來？

菠蘿酵素雖然存在於菠蘿的每一個部分，但主要集中在菠蘿莖部。市面上大多數的菠蘿產品，均是將菠蘿切片、罐裝或榨成果汁。而菠蘿產品的剩餘部份，就蘊含著豐富的菠蘿酵素，我們可從這些剩餘部份提取菠蘿酵素。菠蘿酵素因為其分解蛋白質的能力而起初用作鬆肉粉，但現在的研究證實，粉狀的菠蘿酵素能促進健康。

菠蘿酵素如何支持細胞健康？

有些細胞在免疫系統中以蛋白層作為擋箭牌，「偽裝」成無害的細胞。而蛋白酵素，例如菠蘿酵素就能幫助支援你的免疫系統檢測這些細胞。這些酵素可支持你的身體進行「細胞內部大掃除」，維持細胞健康。

我是一個非常好動的人。Isotonix菠蘿酵素沖飲如何支援身體的正常修復及癒合能力？

體力活動，例如運動、慢跑、舉重訓練、健美操及武術都會對身體組織構成壓力或加速氧化劑形成。

Isotonix菠蘿酵素沖飲是強大蛋白酵素的濃縮配方，專為支援健康身體正常組織恢復及修復過程而設。保持你的身體組織健康，是你擁抱健康生活的第一步。

Isotonix菠蘿酵素沖飲適合素食者嗎？

適合。

Isotonix菠蘿酵素沖飲可與什麼Isotonix等壓吸收產品配合使用？

Isotonix菠蘿酵素沖飲可配合Isotonix健將配方使用，效果更佳。Isotonix健將配方促進肌肉和骨骼健康，提供抗氧化防護，減低運動時所產生自由基對身體的影響。Isotonix菠蘿酵素沖飲支援身體的炎症反應、正常癒合、組織恢復及修復過程。此外，它亦支持細胞健康，為免疫系統提供額外保護。

食用Isotonix菠蘿酵素沖飲安全嗎？

Isotonix菠蘿酵素沖飲安全及不含有害物質。本產品在美國製造，並於經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

甚麼是Isotonix全效維他命B群沖飲？
Isotonix全效維他命B群沖飲是等壓的營養組合，其中包含人體所需的必要B類維他命、鎂及鉀。這些營養互相合作，支援人體多方面的健康及生物過程。Isotonix全效維他命B群沖飲為人體提供維他命B12、B2（核黃素）、B6、葉酸、維他命B3（菸鹼酸）、B5、B1及生物素。葉酸與B12合作能分解、利用及製造新蛋白質。維他命B5則參與能量產生過程，並是製造神經傳導物乙膽鹼的必要成份，亦是由脂肪產生、輸送及釋放能量的必要元素。硫胺素、核黃素、菸鹼酸及生物素從多方面參與能量產生的過程。

如果一個人缺乏內因子並需要注射B12，使用Isotonix全效維他命B群沖飲對他／她有幫助嗎？
沒有。維他命B12需要一種內因子才能被適當吸收，此內因子是一種由胃壁細胞合成的蛋白質，才能與維他命B12結合。

為甚麼B類維他命對衰老過程那麼重要？
隨著年紀漸長，吸收B類維他命的能力自然下降，而認知功能受損的多種指標與B類維他命水平下降有關。長者普遍會因味覺下降而影響食慾，可能會利用很多減少胃酸的藥物，這會令他們容易缺乏維他命B12。維他命B12是極難消化和吸收的營養，同時也是參與多種人體功能的重要維他命之一；這些功能包括理想的神經系統功能、正常的脫氧核糖核酸（DNA）及核糖核酸（RNA）合成、能量產生及健康的血液。

飲用Isotonix B群沖飲有特定方法嗎？
Isotonix全效維他命B群沖飲可與其他Isotonix產品一併空肚飲用。

我既年輕又健康，為甚麼要飲用B群呢？
健康專家估計，每五個成年人中，就有一個缺乏足夠B類維他命。茹素、酗酒、服食大量處方或非處方藥物、消化功能不全、接受過胃部繞道手術或飲食不均衡的人士，尤其容易缺乏足夠維他命B。

Isotonix全效維他命B群沖飲有哪些警告或禁忌嗎？
如果你正在服用處方藥物或患有長期疾病，使用本產品前請諮詢醫護人員。

應該如何使用Isotonix全效維他命B群沖飲？
將一小瓶蓋（白色螺旋蓋）的粉末倒入透明瓶杯中，加水至瓶杯線上（60毫升），攪拌後飲用。本品為健康食品，每天飲用一次或按醫護人員指示飲用。空肚時飲用效果最佳。使用規定量的粉劑與水混合才會使本產品達到等滲狀態。

甚麼產品與Isotonix全效維他命B群沖飲使用效果最佳？
本產品可配合任何其他補充品使用，視乎你的營養需要而定。如希望提升能量，可使用Isotonix全效維他命B群沖飲與Isotonix巴西莓提升能量沖飲；如希望紓緩情緒，可使用Isotonix全效維他命B群沖飲與Isotonix左旋色胺酸沖飲。

飲用Isotonix全效維他命B群沖飲安全嗎？
Isotonix全效維他命B群沖飲安全及不含有害物質。本產品在美國製造，並於經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

• Bromelain Monograph. Alternative Medicine Review. 15: 361-368, 2010.
• Müller S, März R, Schmolz M, Drewelow B, Eschmann K, Meiser P. Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration – new evidence on the antiinflammatory mode of action of bromelain. Phytother Res. 27(2):199-204, 2013.
• Cirelli M. Treatment of inflammation and edema with bromelain. A plant proteolytic enzyme concentrate. Del Med J. 1962 Jun;34:159-67, 1962.
• Brien S, Lewith G, Walker A, Hicks SM, Middleton D. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies. Evid Based Complement Alternat Med. Dec;1(3):251-257, 2004.
• Bhattacharyya Barun. Bromelain: An Overview. Natural Product Radiance. 7(4):359-63, 2008.
• Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002;9:681-6.
• Nouza K. Physical activity and immune system. Systemic enzyme therapy in prevention and treatment. Medicina Sportiva Boh Slov. 1997; 6(2):41–45.?
• Vellini M, Desideri D, Milanese A, et al. Possible involvement of eicosanoids in the pharmacological action of bromelain. Arzneimittelforschung 1986;36:110-112.
• Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 2002;104:183-90.
• Rajendra Pavan, Sapna Jain, Shraddha, Ajay Kumar. Properties and Therapeutic Application of Bromelain: A Review. Biotechnol Res Int. 1-6, 2012.
• Klein G, Kullich W, Schnitker J, Schwann H. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 24(1):25-30, 2006.
• Tilwe GH, Beria S, Turakhia NH, Daftary GV, Schiess W. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: an open randomized controlled clinical trial. J Assoc Physicians India. 49:617-21, 2001.
• Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir M. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee–a double-blind prospective randomized study. Clin Rheumatol. 2004 Oct;23(5):410-5. Epub 2004 Jul 24.
• Singer F., Singer C., Oberleitner H. Phlogenzym® versus Diclofenac in the treatment of activated osteoarthritis of the knee. A double-blind prospective randomized study. Int. J. Immunotherapy. 17: 135-14, 2001.
• Schmid B, Kotter I, Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J Clin Pharmacol. 57:387-91, 2001.
• Chrubasik S, Eisenberg E, Balan E, et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med 109:9-14, 2000.
• Fiebich BL, Chrubasik S. Effects of an ethanolic salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine. 11:135-8, 2004.
• Biegert C et al. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. Journal of Rheumatology. 31.11 (2004):2121-30.
• Khayyal MT et al. Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract. Arzneimittel forschung. 55.11:677-87, 2005.
• Schmid B et al. “Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial.” Phytotherapy Research. 15.4 :344-50, 2001.
• Bhattacharyya Barun. Bromelain: An Overview. Natural Product Radiance. 7(4):359-63, 2008.
• Blonstein JL. Control of swelling in boxing injuries. Practitioner 1960; 185:78.
• Tassman GC, Zafran JN, Zayon GM. Evaluation of a plant proteolytic enzyme for the control of inflammation and pain. J Dent Med 1964;19:73-77.
• Tassman GC, Zafran JN, Zayon GM. A double-blind crossover study of a plant proteolytic enzyme in oral surgery. J Dent Med 1965;20:51-54.
• Masson M. Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practice. Fortschr Med 1995;113:303-306.
• Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002;9:681-6.
• Kamenícek V, Holán P, Fran?k P. Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling. Acta Chir Orthop Traumatol Cech. 2001;68(1):45-9.
• Kerkhoffs GM, Struijs PA, de Wit C, Rahlfs VW, Zwipp H, van Dijk CN. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes. Br J Sports Med. 2004 Aug; 38(4):431–435.
• Gläser D, Hilberg T. The influence of bromelain on platelet count and platelet activity in vitro. Platelets. 2006 Feb;17(1):37-41.
• Bhattacharyya Barun. Bromelain: An Overview. Natural Product Radiance. 7(4):359-63, 2008.
• Heinicke RM, Van der Wal M, Yokoyama MM. Effect of bromelain on human platelet aggregation. Experientia 1972;28:844-845.
• Morita AH, Uchida DA, Taussig SJ. Chromatographic fractionation and characterization of the active platelet aggregation inhibitory factor from bromelain. Arch Inter Phar Ther 1979;239:340-350.
• Nieper HA. Effect of bromelain on coronary heart disease and angina pectoris. Acta Med Empirica 1978;5:274-278.
• Nieper HA. Decrease of the incidence of coronary heart infarct by Mg- and K-orotate and bromelain. Acta Med Empirica 1977;12:614-618.
• Seligman B. Oral bromelain as adjuncts in the treatment of acute thrombophlebitis. Angiology 1969;20:22-26.
• Krivoy N, Pavlotzky E, Chrubasik S, et al. Effect of salicis cortex extract on human platelet aggregation. Planta Med. 209-12, 2001.
• Chobotova K, Vernallis AB, Majid FA. Bromelain’s activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Lett. 28;290(2):148-56, 2010.
• Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988;22:191-203.
• Taussig SJ, Szekerczes J, Batkin S. Inhibition of tumor growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus). Planta Med 1985;6:538-539.
• Batkin S, Taussig SJ, Szekerezes J. Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity. J Cancer Res Clin Oncol 1988;114:507.
• Desser L, Rehberger A, Paukovits W. Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother 1994;9:253-263.
• Desser L, Rehberger A. Induction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes. Oncology 1990;47:475-477.
• Desser L, Rehberger A, Kokron E, et al. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 1993;50:403-407.
• Rajendra Pavan, Sapna Jain, Shraddha, Ajay Kumar. Properties and Therapeutic Application of Bromelain: A Review. Biotechnol Res Int. 1-6, 2012 .